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Abstract
The aim of this study was to evaluate the behavior of human Dental Pulp Stem Cells (DPSCs), as well as human osteoblasts,
when challenged on a Biocoral scaffold, which is a porous natural hydroxyapatite. For this purpose, human DPSCs were
seeded onto a three-dimensional (3D) Biocoral scaffold or on flask surface (control). Either normal or rotative (3D) cultures
were performed. Scanning electron microscopic analyses, at 8, 24 and 48 h of culture showed that cells did not adhere on
the external surface, but moved into the cavities inside the Biocoral structure. After 7, 15 and 30 days of culture,
morphological and molecular analyses suggested that the Biocoral scaffold leads DPSCs to hook into the cavities where
these cells quickly start to secrete the extra cellular matrix (ECM) and differentiate into osteoblasts. Control human
osteoblasts also moved into the internal cavities where they secreted the ECM. Histological sections revealed a diffuse bone
formation inside the Biocoral samples seeded with DPSCs or human osteoblasts, where the original scaffold and the new
secreted biomaterial were completely integrated and cells were found within the remaining cavities. In addition, RT-PCR
analyses showed a significant increase of osteoblast-related gene expression and, above all, of those genes highly expressed
in mineralized tissues, including osteocalcin, OPN and BSP. Furthermore, the effects on the interaction between
osteogenesis and angiogenesis were observed and substantiated by ELISA assays. Taken together, our results provide clear
evidence that DPSCs differentiated into osteoblasts, forming a biocomplex made of Biocoral, ECM and differentiated cells.
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Introduction
Bone grafting to replace missing bone with synthetic porous
Biomaterial (i.e. bone graft scaffolds) and associated new bone
formation and remodelling, have been investigated for over 30
years [1]. Limited availability of autografts and the risk of disease
transfer of allografts, however, has produced an increase in
requests for synthetic bone grafts.
Novel approaches for bone substitutes are focused on stimulation
of osteointegration, osteoconduction, osteoinduction as well as
induction of angiogenesis and vascularisation, by designing
bioactive materials with appropriate pore architecture [1].
On the other hand, the scaffolds used in tissue engineering for
bone regeneration must also act as a template for cell adhesion,
migration, proliferation, cell to cell interactions and the formation
of bone-extracellular matrix, providing structural support to the
newly formed tissue.
In addition, they can serve as delivery vehicles for cytokines
such as bone morphogenetic proteins (BMPs), insulin-like growth
factors (IGFs) and transforming growth factors (TGFs) that
stimulate recruited host precursor cells to differentiate into bone-
matrix producing cells [2], thus providing osteoinduction. Finally,
scaffolds for osteogenesis should have an interconnected porosity
so as to help tissue integration and vascularisation.
Porous scaffolds are thought to have all these features: they are
utilized to induce good bone healing by three-dimensional tissue
growth.
Due to their interconnected porous architecture, high compres-
sive breaking stress, good biocompatibility and reabsorbability,
corals have been used as scaffolds for bone tissue engineering.
Transcortical bony defects implanted with coral become vascu-
larised and are invaded by newly formed bone, whereas the coral
is reabsorbed at a rate commensurate with bone formation [3].
It has been postulated that greater regeneration could be
obtained by supplementing a reabsorbable scaffold with osteogenic
cells such as bone marrow stromal cells (BMSCs) or umbilical
cord-derived stem cells to improve clinical outcome [4,5,6]. Stem
cell–based tissue engineering has been shown to be highly
advantageous in bone regeneration when adult mesenchymal
stem cells (MSCs) are used.
Therefore taking into consideration that human dental pulp
stem cells (DPSCs) are MSCs that quickly differentiate into
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18721osteoblasts and endothelial cells both in vitro and in vivo [7,8], and
are able to successfully repair human bone defects [9] we decided
to use these cells, and primary human osteoblasts for comparison,
to observe their capabilities on a Biocoral scaffold.
Our main objective was to study the osteogenic differentiation
of DPSCs or human osteoblasts, challenged on a Biocoral scaffold,
as well as to provide fundamental information allowing the use of
DPSCs/Biocoral as a suitable engineered biocomplex, made of
human mesenchymal-derived cells and a porous structure, for
defect repair or transplantation purposes.
Results
Cell growth analysis
Cell growth analysis and viability staining with trypan blue
showed that the scaffold did not show significant effects on the
viability of each cell population with respect to its control (flask
surface).
The cell doubling time was of 4560.29 hours for DPSCs seeded
in flasks and of 45.760.18 hours for DPSCs grown on scaffolds.
For osteoblasts, the doubling time was of 3460.15 hours for cells
seeded in flasks versus 33.860.25 for those grown on Biocoral.
Cultures and scanning electron microscopy
DPSCs isolated from the dental pulps of healthy individuals
were sorted for c-kit/CD34/flk-1. Both primary osteoblasts and
DPSCs were seeded on Biocoral scaffolds, as well as on flasks (flask
surfaces) in standard cultures and then processed for scanning
electron microscope (SEM) analysis at 4, 8 and 24 h. Cell density
and morphology on both surfaces were investigated. On Biocoral
surfaces, a very small number of cells (either DPSCs or osteoblasts)
was detectable at the times considered (data not shown). This can
be due to the fact that cells that quickly moved into the cavities
inside the Biocoral, rich in depressions and deep, rounded pits of
widely varying shape and size (Fig. 1A–D). In Biocoral cavities,
cells were attached to the surface and did not show a flattened or
spherical shape (Fig. 1 E–H). Cells seemed to reach a stabilized
shape only after 8 h of culture, although DPSCs (Fig. 1 E,F) and
primary osteoblasts displayed osteoblastic features at 24 h (Fig. 1
G, H).
Histological evaluation
Histological sections of DPSCs and osteoblasts seeded on
Biocoral showed a diffuse bone formation within this scaffold,
although it was impossible to establish the exact amount of new
bone deposition, because it was disseminated within the internal
cavities (Fig. 2 A,B). In the control sample (Fig. 2C), being the
Biocoral made of hydroxyapatite and having a bone-like structure,
it displays the same Alizarin red staining of mineralized structures
detectable for both DPSCs and osteoblasts. The cells were clearly
observable in all the samples, inside the structure and up to the
surface of the pores (Fig. 2 A,B). In particular, it was possible to
observe that cells were located inside the cavities.
Toluidine blue staining confirmed the presence of cells and their
colonization inside the Biocoral, entrapped in it (Fig. 2 C). On
flask surfaces, mineralized bone nodules formation was observed
and stained with Alizarin red (Fig. 2D).
Expression of bone-associated genes
To evaluate the effects of the Biocoral scaffold on osteogenic
differentiation, we performed RT-PCR analyses for bone-
associated genes in DPSC cultures either grown on Biocoral
scaffold, or on a flask surface, at different times of their
differentiation (7-15-30 days). Osteoblasts grown in the same
conditions, as mentioned above, were used as controls.
RT-PCR analyses (Fig. 3 and Tables 1 and 2) revealed that no
differences for Runx-2 expression were detectable in DPSCs
seeded both on the Biocoral scaffold and on flask surfaces,
although its expression increased from day 7 to day 15.
Conversely, in osteoblasts, Runx-2 expression considerably
decreased in cells seeded on Biocoral scaffold.
Figure 1. Scanning electron microscopy (SEM) micrographs. This figure shows the Biocoral scaffold structure at different magnification (see
scale bars at the bottom of each micrograph) (A–D) evidencing size and regularity of porosity and pore interconnections. SEM micrographs showing
(E–F) DPSCs and (G–H) human osteoblasts grown on Biocoral scaffold at 8 h and 24 h after seeding. Cell adhesion and spreading on scaffold porosity
can be observed.
doi:10.1371/journal.pone.0018721.g001
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considered in our observations. Actually, its expression showed a
slight but progressive increase from day 7 to day 15 in both DPSCs
and osteoblasts.
Bone Alkaline Phosphatase (BAP) was highly expressed by
DPSCs on both Biocoral and flask surfaces, while osteoblasts
showed a lack of expression, when cultured on Biocoral scaffold.
The expression of Osteopontin, which is considered one of the
major sialoprotein of the extracellular matrix of bone and serves as
a bridge between cells and hydroxyapatite [10], was increased at
day 30 in DPSCs and already at day 7 in osteoblasts grown on
Biocoral scaffold.
Osteonectin, a glycoprotein that binds calcium and that is
secreted by osteoblasts during bone formation, initiating mineral-
ization and promoting mineral crystal [11], was shown to be
considerably expressed in all DPSCs samples at the same levels,
while ii was slightly decreased in osteoblasts grown on Biocoral
scaffold.
Bone sialoprotein (BSP), a significant component of the bone
extracellular matrix was slightly expressed by DPSCs, but its
expression was up-regulated starting from day 15 on Biocoral
scaffold. The same results were detected in osteoblasts.
Noteworthy, the expression of osteocalcin, which is a late stage
marker of osteogenic differentiation, was found to be strongly
increased in the presence of the Biocoral scaffold in both DPSCs
and osteoblasts, with respect to their controls during the osteoblast
differentiation.
Moreover, we analyzed also BMP-2 and VEGF expression.
Regarding BMP-2 expression, it was significantly up-regulated in
DPSCs seeded in the Biocoral scaffold, with respect to DPSCs
seeded in the flask surfaces. In osteoblasts no significant differences
were detectable.
RT-PCR analyses revealed that VEGF, which is a potent
angiogenic stimulator that plays an important role during bone
formation, was highly expressed in all the samples.
ELISA assays
ELISA assays (Fig. 4) were performed on culture media in order
to detect the amounts of VEGF and BMP-2 growth factors at 7, 15
and 30 days. The time steps were chosen in order to understand
the kinetics of the relative amounts of both morphogens secreted
by the cells (DPSCs or osteoblasts) in both conditions: seeded and
cultured either on the Biocoral scaffold or on a flask surfaces.
VEGF. The amount of VEGF secreted by DSPCs
considerably and significantly increased from 7 up to 30 days on
Biocoral scaffold (p,0.01) (Fig. 4A); interestingly, the amounts of
VEGF secreted by cells seeded on Biocoral were significantly
higher than those found in samples on flask surfaces (p,0.01)
(Fig. 4A) .
On the other hand, VEGF amounts secreted by osteoblasts on
flask surfaces were found to be significantly decreased from day 15
up to day 30. In addition, the VEGF amount belonging to
Biocoral samples, when compared with the amounts belonging to
osteoblasts in flask surface, were found to be significantly higher
(p,0.01). (Fig. 4B)
BMP-2. From 7 to 30 days, while BMP-2 amounts released by
DSPCs on flask surfaces were found to be of low amounts, those
secreted by cells cultured with Biocoral scaffolds were found to be
significantly increased up to 15 days (p,0.01), although they had
then dropped at day 30 (Fig. 4 C).
In addition, the amounts of BMP-2 levels secreted by osteoblasts
on Biocoral were much higher (p,0.01) than those secreted by
osteoblasts on flasks at day 7, then these levels tended to decrease
by day 15 days of culture, up to day 30 (Fig. 4 D).
Discussion
Up to a few years ago, the gold standard for bone grafting
surgical procedures was considered to be the use of autologous
bone grafts, capable to stimulate bone growth and implant
fixation. However, limited amounts of bone are available for
autografting and the harvesting procedures involve high donor site
Figure 2. Histological sections. Light microscopic images showing the Biocoral scaffold that is (A) loaded with DPSCs after 30 days of 3D culture
and stained with Alizarin red and Toluidine Blue or (D) only with Toluidine Blue, showing the red staining of bone and the blue staining of cells
(arrows) that are completely entrapped within the Biocoral cavities; or (B) loaded with human osteoblasts after 30 days of 3D culture and stained with
Alizarin red and Toluidine Blue or (E) only with Toluidine Blue, also showing the red staining of bone and the blue staining of entrapped cells (arrows),
inside the Biocoral cavities; (C) Alizarin red and Toluidine blue staining of Biocoral without cells. Arrows indicate Biocoral cavities without cells; (F) the
Alizarin red stains a calcification nodule (arrow) obtained from DPSCs cultured for 30 days on a flask surface (control). Original magnification 4006.
doi:10.1371/journal.pone.0018721.g002
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PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e18721Figure 3. RT-PCR analyses for osteoblast-specific genes. The analyses were performed on the following genes: Osterix, Runx-2, Osteocalcin,
VEGF, BMP-2, osteonectin, BAP, BSP, osteopontin (OPN). It is possible to observe that at 7, 15 and 30 days of culture cells grown on flask surface (lane
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but the complication rate is high with the risks of graft-versus-host
disease, transmission of infectious diseases and graft failure
[12,13,14]. Therefore, alternative methods including those using
stem/progenitor cells have been recently investigated [7,8,15] and
human trials have already been successfully carried out [9].
Actually, in bone tissue engineering, mainly regarding large
defects, a possible strategy involves the culture of osteogenic cells
on porous scaffolds. Osteogenesis occurs by seeding the scaffolds
before implantation with cells that will establish new centres for
bone formation [2], such as osteoblasts and mesenchymal cells that
have the potential to commit to an osteoblastic lineage. The aim is
to achieve a tool for bone grafting by using autologous
mesenchymal stem cells (MSC). Human MSCs (hMSCs) are an
attractive cell source because they are readily extracted from
several sites in humans such as adipose tissue, dental pulp or bone
marrow [4,5,6]. Among the hMSCs, dental pulp stem cells have
been demonstrated to be ideal for their use in bone differentiation
and tissue engineering [7,8,9,15] .
Natural coral exoskeleton has the best mechanical properties of
the porous calcium-based ceramics, given that its pores range from
150 to 600 mm in diameter, with interconnecting pore sizes
averaging approximately 260 mm in diameter. These dimensions
are similar to that of spongy bone, thus making coral an excellent
base for the spread of new bone ingrowth. In addition, calcium-
phosphate materials can be technologically modified, chemically
and structurally designed with specific architecture, forms, and
geometry [16] . All of these properties could drive cell functions,
forcing cells to express the desired osteogenic phenotype [17] .
On the other hand, we have recently demonstrated [18] that a
sintered titanium surface, due to its specific topographical
characteristics, allows DPSCs to quickly differentiate into
osteoblasts and produce considerable amounts of bone with
respect to other titanium surfaces (machined) meaning that the
scaffold’s surface is of paramount importance for cell differenti-
ation and fate.
In the present study we show that stem cells quickly move within
Biocoral cavities and then they start to differentiate into
osteoblasts. Differentiation and matrix mineralization in vitro
involve a considerable expression of genes as well as protein
production, leading to the mineralization.
Our findings demonstrate that Biocoral scaffold induced an
increase osteoblast-related gene expression in DPSCs. In fact, we
observed an increase in mRNA expression of the bone-associated
transcription factors, like Osterix and Runx-2 and a strong up-
regulation of osteocalcin, a marker of late-stage osteoblast
differentiation. These findings suggest that DPSCs are differenti-
ating into osteoblasts.
Furthermore, to assess the effects on mineral formation, we
decided to detect BSP and OPN mRNA expression and we found
that both BSP and OPN mRNAs were up-regulated in DPSCs
culture grown on Biocoral. Taking into consideration that
formation of mineralized matrix is a definitive hallmark of
osteoblastic differentiation, we can assume that Biocoral scaffold
stimulates osteoblast differentiation and function inducing matrix
mineralization as confirmed also by Alizarin Red staining.
On the other hand, the osteoblast cell culture, that we used as a
control, underwent bone differentiation, since these cells are
already self-committed. In fact, osteoblasts cultured on the
Biocoral scaffold showed a high expression of the late-stage
differentiation markers, including OPN, BSP and osteocalcin,
whereas the expression of early-stage markers, like Runx-2, BMP-
2 and BAP, decreased. The findings can be also explained
considering that, as it is well known, the expression of Runx-2 and
BAP in bone formation has an important role in the early and
middle stages of differentiation, while the expression of BSP, OPN
C) or on Biocoral (lane B) were analyzed for the expression of early, middle and late stage osteoblast differentiation genes. See Table 1 and 2 for
quantification data.
doi:10.1371/journal.pone.0018721.g003
Table 1. Densitometry measurement of mRNA level for DPSCs sedeed on Biocoral scaffold (B) and flask surface(C).
Day Osterix Runx-2 Osteocalcin
CB CB CB
7 0.44960.11 5.77660.92** 4.38060.91 6.11461.12 0.042660.03 1.07060.24**
15 12.260.53 12.45660.45 10.32560.70 11.12560.68 0.05560.04 0.95360.13**
30 12.54860.64 12.46060.59 10.01460.82 12.28660.95 0.18160.09 1.01960.15**
VEGF BMP-2 Osteonectin
CB CB CB
7 7.89161.15 9.54360.92 10.63860.24 14.50960.35* 9.19760.79 8.06960.93
15 9.69760.81 8.54060.63 5.10460.16 15.86560.98** 10.51460.81 9.36461.54
30 8.66560.27 9.05960.12 8.40660.31 15.49060.43** 11.07061.06 9.55861.87
BAP BSP Osteopontin
CB CB CB
7 13.86060.12 10.02562.89 1.66160.01 1.66560.01 2.50860.37 6.74860.45**
15 12.69760.79 11.57261.81 3.64160.58 5.90160.34* 4.91560.79 6.03560.13




Biocoral and DPSCs for Bone Repair
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e18721and osteocalcin has a significant role in the late stages of osteoblast
differentiation.
In addition, in this study, we have assayed the amount of
morphogens secreted by stem cells and osteoblasts by ELISA
assay. Our results show that the amount of BMP-2 and VEGF
secreted by DPSCs seeded on Biocoral scaffold were increased
with time, with respect to the already differentiated cells, thereby
establishing the interaction between osteoblast function and
angiogenesis which are combined, closely associated processes
leading to bone formation [7], although these data do not agree
with RT-PCR analyses. Post-transcriptional regulations of gene
expression enable cells to control the contents of their proteomes.
Therefore, the protein production does not always show the same
trend of m-RNA expression. Post-transcriptional regulations could
be occurred justifying different results between RT-PCR and
ELISA for VEGF analyses. The latter may explain the differences
that we have found and described.
In conclusion, with this study we provide clear evidence that
stem cells (namely DPSCs) differentiating into osteoblasts lead to a
biomineralization, supported by the bioscaffold surface, that is
capable to induce a rather complex gene expression as well as
bone morphogenetic protein production. The biocomplex made of
osteoblasts originating from dental pulp stem cells and Biocoral
seems to be a reliable new tool for bone tissue engineering.
Materials and Methods
Dental pulp extraction and digestion
Human dental pulp was extracted from third molar teeth of 8
healthy adults with written informed consent, approved by our
Internal Ethical Committee (Second University Ethical Commit-
tee) and following our protocol [8]. Before extraction, each subject
was checked for systemic and oral infection or diseases. Only
disease-free subjects were selected. Each subject was pretreated for
a week with professional dental hygiene. Before extraction, the
dental crown was covered with 0.3% chlorhexidine gel (Forhans,
NY, USA) for 2 min and then the pulp was extracted with a
dentinal excavator or a Gracey curette.
Dental pulp stem cell and primary osteoblasts cultures
Once removed, each pulp was immersed in a digestive solution
(type I collagenase 3 mg/ml plus dispase 4 mg/ml in phosphate
buffer saline, PBS, containing 100 U/ml penicillin, 100 mg/ml
streptomycin) for 1 h at 37uC in agitation. The solution was then
filtered through 70 mm Falcon strainers (Becton and Dickinson,
Franklin Lakes, NJ, USA). After filtration, cells were pooled and
immersed in MegaCell Minimum Essential Medium (Sigma,
Milan, Italy) supplemented with 10% FBS, 100 mM 2P-ascorbic
acid, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml
streptomycin (all purchased from Invitrogen, San Giuliano
Milanese, Milan, Italy) and placed in 75 ml flasks with filtered
valves. Flasks were incubated at 37uC and 5% CO2 and the
medium changed twice a week. Just before cells become confluent,
they were subdivided into new flasks. Stem cells were sorted (see
below) only when their number was at least 1,000,000 cells per
flask. This number was achieved around day 22, when they were
still undifferentiated. Differentiated cells were obtained from
sorted stem cells cultured for at least 30 days in a-MEM culture
medium with 20% FBS (all purchased from Invitrogen, San
Giuliano Milanese, Milan, Italy); in fact, FBS promotes osteoblas-
tic differentiation when used at a high percentage, as we have
previously demonstrated [8,19].
Human osteoblasts were obtained from cortical mandible of
healthy patients free of bone-related disease, who underwent of
third molar extraction. Bone chips were rinsed three times in
phosphate buffered saline (PBS), broken into small pieces and
cultured in alpha-MEM supplemented with 10% FBS. Primary
osteoblast cultures were kept in a humidified atmosphere of 5%
CO2 at 37uC. Both DPSCs and primary osteoblasts were seeded
onto Biocoral scaffolds of constant size (5 mm diameter and
1,5 mm thick); 200 mlo f1 0
5cells/ml were seeded onto each
scaffold in 24-well plates with a sterile syringe. Cells were
Table 2. Densitometry measurement of mRNA level for osteoblasts sedeed on Biocoral scaffold (B) and flask surface(C).
Day Osterix Runx-2 Osteocalcin
CB CB C B
7 9.45261.01 6.85860.95 9.55461.4 8.13362.01 0.89060.12 1.09060.23*
15 7.28460.62 7.51061.23 11.76660.81 3.65660.54** 0.78060.14 1.13460.35*
30 6.09460.76 6.90560.45 10.13660.34 2.51060.92** 0.75460.28 1.10460.35*
VEGF BMP-2 Osteonectin
CB CB C B
7 8.42160.67 8.47760.86 5.38860.53 3.34661.98 8.39260.43 4.79960.56*
15 7.40060.89 7.99661.21 6.05960.48 4.58061.03 9.33260.67 6.49460.55*
30 7.27160.97 7.04161.11 5.94260.93 4.67261.24 7.91060.71 5.30160.49*
BAP BSP Osteopontin
CB CB C B
7 5.35260.67 0.64160.13** 13.96161.10 6.79063.76 4.87560.87 14.47161.14**
15 11.21660.84 3.10460.12** 12.19860.92 14.79660.75* 6.93960.79 11.62261.11**
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adding the culture medium to a total volume of 1 ml.
Biocoral Scaffold
The calcium-carbonate coral-derived material (Genus Porites)
evaluated in this study presents a chemical composition very
similar to human bone [20]. Biocoral consists of more than 98%
calcium carbonate in crystal form (aragonite) and other elements
(F and Sr 0.7–1%, Mg 0.05–0.2%,Na,1%, K,0.03%,
P,0.05%, water,0.5%, and amino acids,0.026%). Among all
these elements, the presence of strontium is fundamental, as it can
effectively promote mineralization processes [21]. Biocoral is
biocompatible and osteoconductive and interestingly, it possesses
an average porosity of 50% and it is similar to cancellous bone,
with an architecture composed by strongly interconnected pores of
variable diameter (250–500 mm).
Tissue engineering and rotating cultures
In order to achieve 3-dimensional tissue formation, we
challenged DPSCs and primary osteoblasts in a roller apparatus
(Wheaton, Millville, NJ) with Biocoral scaffold.
At least 500,000 cells after sorting were gently plated onto 3-
dimensional scaffolds made of Biocoral. Samples were placed in
the roller apparatus and left for 30 days at a speed of 6 rpm in an
incubator at 37uC and 5% CO2. At the end of the experiments, all
the specimens were processed for histological observations, as
specified below.
FACScanning, sorting and differentiation
Cells were sorted using both morphological traits (high side
scatter and low forward scatter) and antigenic criteria (firstly using
CD117 and CD34, and then flk-1), as specified previously
[7,8,9,19]. Only cells that co-expressed all these markers (5% of
total cell population) were sorted in order to obtain a
homogeneous population, called DPSC. Briefly, cells were
detached using 0.02% EDTA in PBS and pelleted by centrifuga-
tion (10 min at 1,000 rpm), washed in PBS at 0.1% BSA at 4uC
and incubated with 1 mg/ml of antibody. Cells were washed in the
same solution once and were processed for sorting (FACsorter
ARIA II, Becton & Dickinson, Franklin Lakes, NJ, USA). The
mouse anti-human antibodies CD117 (c-kit), CD34, and flk-1 were
purchased from DBA, Segrate, Milan, Italy.
For indirect immunofluorescence cytometric assay, FITC and
PE-labeled goat anti-mouse (Santa Cruz) were used. The purity of
sorted populations was routinely 90%. Isotype antibodies were
used as controls.
Osteogenic differentiation was achieved as previously reported
[7,8,9]. Briefly, SBP-DPSCs were cultured with 20% FBS for 15
days without passaging, after which cells were cultured with 20%
FBS. We have extensively demonstrated that SBP-DPSCs do not
require dexametasone or addition of other substances to achieve
osteodifferentiation and bone production (Laino et al, 2005; 2006,
d’Aquino et al., 2007). To monitor differentiation, the cells were
examined using mouse anti-human antibodies to CD44, the
transcription factor Runx-2 (all from Santa Cruz, CA, USA). For
Runx-2 analysis, cells were processed using the Caltag Fix & Perm
Kit (Invitrogen, Milan, Italy) following the manufacturer’s
guidelines. Isotypes were used as controls. All data were analyzed
using CellQuest software.
Figure 4. ELISA assays for BMP-2 and VEGF protein secretion.
These observations were performed on DPSCs and human osteoblast
secretions at 7, 15 and 30 days of culture. Data are given as average
values 6SD. *p,0.001.
doi:10.1371/journal.pone.0018721.g004
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In order to assess the scaffold’s ability to sustain cell growth and
expansion (of both DPSCs and osteoblasts), growth curves for cells
seeded on scaffolds versus cells seeded on flask surfaces were
compared. For this purpose, cells were seeded in equal densities in
24 well-plates (see above) and harvested by trypsinization. After
washing in PBS, the cell suspension was diluted 1:1 with 0.4%
trypan blue solution (Sigma–Aldrich), and viable and non-viable
cells were counted using the hemocytometer chamber under an
inverted microscope. Cells from triplicate samples were considered
at 24 h intervals for 10 days. The average cell count of each day
was used to determine growth curves and doubling time.
Scanning electron microscope (SEM)
Cells were fixed in 2.5% glutaraldehyde (EM grade) in 0.1 M
phosphate buffer, postfixed in 0.1% OsO4 in the same buffered
solution for 1 h and, after critical point drying and gold-palladium
coating, observed by SEM (JEOL-6700F, Tokyo, Japan).
Histological evaluations
As above specified, after 3-D culture, all the specimens were
immersed in a fixative solution of 10% buffered formalin at
pH 7.2 with 0.1 M sodium phosphate, for 4 h at room
temperature and left overnight at 48uC. The specimens were
processed to obtain thin ground sections with the Precise 1
Automated System (Assing, Rome, Italy). The specimens were
dehydrated in an ascending series of alcohol rinses and embedded
in a glycolmethacrylate resin (Techonovit 7200 VLC; Kulzer,
Wehrheim, Germany). After polymerization, the specimens were
sectioned along their longitudinal axis with a high-precision
diamond disc to about 150 mm and ground down to about 30 mm
with a specially designed grinding machine. The slides were
stained with alizarin red or toluidine blue. The slides were
observed in normal transmitted light under a Leitz-Laborlux
microscope (Laborlux S, Leitz, Wetzlar, Germany). The histo-
morphometry was performed using a light microscope (Laborlux
S, Leitz) connected to a high-resolution video camera (3CCD JVC
KYF55B), and interfaced to a monitor and personal computer.
This optical system was associated with a digitizing pad (Matrix
Vision GmbH) and a histometry software package with image
capturing capabilities (Image- Pro Plus 4.5; Media Cybernetics
Inc., Milan, Italy). Experiments were performed in quadruplicate.
Alizarin Red staining
For Alizarin Red staining, fixed cells or histological sections
were incubated for 10 min at room temperature in a solution
containing 1% Alizarin Red pH 4.3. Specimens were then washed
with distilled water and viewed under the light microscope.
Semi-quantitative RT-PCR analysis
Total RNA was extracted from specimens at 7, 15 and 30 days
using TRI Reagent (Sigma, Milan, Italy), following the manufac-
turer’s instructions, treated with DNase (Promega) to exclude
DNA contamination and stored at 280uC until the assays. cDNA
synthesis was carried out from total RNA (1 mg) using Superscript
II reverse transcriptase (Invitrogen Celbio Italy, San Giuliano
Milanese, Milan, Italy), and random primers. PCR analyses were
carried out in triplicate using a TC-312 thermal cycler (Techne,
Burlington, NJ, USA), in which samples underwent a 2-minute
denaturing step at 94uC, followed by 35 cycles of 94uC for 30 s,
54–60uC for 60 s, 72uC for 30 s, and a final extension step at 72uC
for 4 minutes. Each PCR reaction was performed in a total
volume of 25 ml containing Tris buffer 10 mM pH 8, 0.2 mM of
each dNTP, 1.5 mM MgCl2, and 0.2 mM of each primer, Taq
DNA polymerase 1 U and 1 ml of each cDNA. The primer
sequences were as follows: RUNX-2 forward, 59-CACTCAC-
TACCACACCTACC-39, reverse 59-TTCCATCAGCGTCAA-
CACC-39; Osterix forward-59-GCAAAGCAGGCACAAAGAA-
G-39, reverse 59-AGGGAATGAGTGGGAAAAGG-39; Osteocal-
cin forward 59-CATGAGAGCCCTCACA-39, reverse 59-AGA-
GCGACACCCTAGAC-39; VEGF forward 59-TGACAGGGAA-
GAGGAGGAGA-39, reverse 59CGTCTGACCTGGGGTAGA-
GA-39; BMP-2 forward 59-CGTGTCCCCGCGTGCTTCTT-39,
reverse 59-GGCTGACCTGAGTGCCTGCG-39; Osteonectin
forward 59-AAACCCCTCCACATTCCC-39, reverse 59-ATTT-
TCCGCCACCACCTC-39; Osteopontin forward 59-GCCGA-
GGTGATAGTGTGGTT-39, reverse 59–TGAGGTGATGTC-
CTCGTCTG-39; BAP forward 59-TCAAACCGAGATACAAG
CAC -39, reverse 59-GGCCAGACCAAAGATAGAGT -39; BSP
forward 59- GGGCAGTAGTG ACTCATCCG -39, reverse 59-
TTCTCAGCCTCAGAGTCTTCA- 39. GAPDH was used as an
internal control. The amplification products were separated on a
2% agarose gel in Tris-acetate EDTA (TAE) buffer. The RT-PCR
experiments were made in triplicate.
ELISA assay
In order to evaluate BMP-2 and VEGF levels in the culture
medium, the complete supernatant medium was collected from
cultures after 7, 15, 30 days from DPSCs and osteoblasts (n=9),
cultured on different surfaces (Biocoral or flask surface). After
centrifugation to remove particulates, 2 ml aliquots were stored at
220uC. After thawing at room temperature, 0.5 ml were collected
from the aliquots and analyzed with an ELISA kit for BMP-2 or
anti-VEGF (R&D, Milan, Italy). The ELISA experiments were
made in triplicate.
Statistical analysis
ANOVA test was used for statistical evaluation. Level of
significance was set at p,0.05.
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